BRPI0810408A2 - Polimorfos de ibandronaro de sódio - Google Patents

Polimorfos de ibandronaro de sódio

Info

Publication number
BRPI0810408A2
BRPI0810408A2 BRPI0810408-5A2A BRPI0810408A BRPI0810408A2 BR PI0810408 A2 BRPI0810408 A2 BR PI0810408A2 BR PI0810408 A BRPI0810408 A BR PI0810408A BR PI0810408 A2 BRPI0810408 A2 BR PI0810408A2
Authority
BR
Brazil
Prior art keywords
ibandronaro
sodium polymorphs
polymorphs
sodium
ibandronaro sodium
Prior art date
Application number
BRPI0810408-5A2A
Other languages
English (en)
Inventor
Surya Narayana Devarakonda
Ram Thaimattam
Balaji Raghupati
Minakshi Asnani
Satish Kumar Vasamsetti
Srinivasulu Rangineni
Vamsi Krishna Muppidi
Original Assignee
Reddys Lab Ltd Dr
Reddys Lab Inc Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reddys Lab Ltd Dr, Reddys Lab Inc Dr filed Critical Reddys Lab Ltd Dr
Publication of BRPI0810408A2 publication Critical patent/BRPI0810408A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839—Polyphosphonic acids
    • C07F9/3873—Polyphosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
BRPI0810408-5A2A 2007-04-19 2008-04-18 Polimorfos de ibandronaro de sódio BRPI0810408A2 (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN849CH2007 2007-04-19
IN400CH2008 2008-02-15
US3148808P 2008-02-26 2008-02-26
PCT/US2008/060727 WO2008131160A1 (en) 2007-04-19 2008-04-18 Ibandronate sodium polymorphs

Publications (1)

Publication Number Publication Date
BRPI0810408A2 true BRPI0810408A2 (pt) 2014-11-04

Family

ID=39577238

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0810408-5A2A BRPI0810408A2 (pt) 2007-04-19 2008-04-18 Polimorfos de ibandronaro de sódio

Country Status (8)

Country Link
US (1) US20100125149A1 (pt)
EP (3) EP2316840A1 (pt)
JP (1) JP2010524967A (pt)
KR (1) KR20100014728A (pt)
AU (1) AU2008242788A1 (pt)
BR (1) BRPI0810408A2 (pt)
NZ (1) NZ580042A (pt)
WO (1) WO2008131160A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2128166A1 (en) * 2008-05-20 2009-12-02 Chemo Ibérica, S.A. Polymorphic forms of Ibandronate sodium and processes for preparation thereof
TR201110526A2 (tr) * 2011-01-06 2012-07-23 Bi̇lgi̇ç Mahmut Kemik hastalıklarının tedavisinde kullanılmak üzere suda çözünebilir farmasötik formülasyonlar.
TR201110524A2 (tr) * 2011-01-06 2012-07-23 Bi̇lgi̇ç Mahmut Kemik hastalıklarının tedavisinde kullanılmak üzere suda çözünebilir yeni formülasyonlar.
WO2013179305A1 (en) * 2012-06-01 2013-12-05 Hetero Research Foundation Ibandronate sodium solid dispersion

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3623397A1 (de) * 1986-07-11 1988-01-14 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
MX2007000087A (es) * 2004-06-23 2007-11-06 Teva Pharma Acido ibandronico solido y cristalino.
DE602005025977D1 (de) * 2004-08-23 2011-03-03 Teva Pharma Kristalline form des ibandronat-natriums und herstellungsverfahren dafür
US7214818B2 (en) * 2004-10-29 2007-05-08 Hoffmann-La Roche Inc. Method for synthesizing bisphosphonate
HUE042316T2 (hu) 2005-02-01 2019-06-28 Atnahs Pharma Uk Ltd Az Ibandronát A polimorf orvosi alkalmazása
EP2363401A1 (en) 2005-02-01 2011-09-07 F. Hoffmann-La Roche AG Ibandronate polymorph B
WO2007013097A1 (en) * 2005-07-25 2007-02-01 Natco Pharma Limited Improved process for the preparation of ibandronate sodium
WO2007074475A2 (en) 2005-12-27 2007-07-05 Natco Pharma Limited Novel polymorphic forms of ibandronate
EP2046342A4 (en) * 2006-07-28 2011-05-04 Reddys Lab Ltd Dr CRYSTALLINE FORM WITH IBANDRONIC ACID AND PROCESS FOR PREPARING THE SAME
US20090012047A1 (en) * 2006-11-16 2009-01-08 Eran Turgeman Crystalline forms of ibandronate sodium
EP1923394A1 (en) * 2006-11-16 2008-05-21 Sandoz A/S Reagent and use thereof for the production of bisphosphonates
EP2144919B1 (en) * 2007-04-11 2015-12-02 F. Hoffmann-La Roche AG Multi step synthesis of ibandronate

Also Published As

Publication number Publication date
KR20100014728A (ko) 2010-02-10
EP2316841A1 (en) 2011-05-04
EP2316840A1 (en) 2011-05-04
NZ580042A (en) 2011-12-22
US20100125149A1 (en) 2010-05-20
JP2010524967A (ja) 2010-07-22
WO2008131160A1 (en) 2008-10-30
AU2008242788A1 (en) 2008-10-30
EP2134731A1 (en) 2009-12-23

Similar Documents

Publication Publication Date Title
NO347644B1 (no) Polymorfer
BRPI0815042A2 (pt) Compostos de pirazol
BRPI0813707A2 (pt) Derivados de pirimidinil-piridazinona
BRPI0820112A2 (pt) Derivados de isoxazol-piridina
BRPI0815067A2 (pt) Compostos de biciclotactama substituída
BRPI0809992A2 (pt) Derivados de pirrolopirimidina
BRPI0820113A2 (pt) Derivados de isoxazolo-piridazina
BRPI0812155A2 (pt) derivados de espiroindolinona
BRPI0817935A2 (pt) Derivados de biarila
BRPI0813500A2 (pt) Compostos antivirais
BRPI0821086A2 (pt) Compostos inseticidas
BRPI0818380A2 (pt) Combinação de herbicida-protetor
BRPI0814236A2 (pt) Derivados de quinazolinamida
BRPI0812518A2 (pt) Derivados de indazolamida
BRPI0820649A2 (pt) Derivados de isoxazalo-pirazina
BRPI0813836A2 (pt) Derivados pirazólicos
BRPI0811264A2 (pt) Compostos
BRPI0915064A2 (pt) derivados de qunoxalinadiona
BRPI0913832A2 (pt) derivados de pirrolopiridinilpirimidin-2-ilamina
DK2152370T3 (da) Aryletherpyridazinonderivater
BRPI0814424A2 (pt) Compostos heterociclila
BRPI0810559A2 (pt) Macadores de doenças
BRPI0814718A2 (pt) Derivados de isoxazol-imidazol
BRPI0913234A2 (pt) derivados de tiazolilpiperidina
BRPI0809996A2 (pt) Compostos

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2329 DE 25-08-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B350 Update of information on the portal [chapter 15.35 patent gazette]